Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 1.76 | £209.44B | 13,554.00 | 0.36% |
| GSK | GSK | FTSE 100 | 3.35 | £74.17B | 1,833.50 | 0.77% |
| HLN | Haleon | FTSE 100 | 1.87 | £32.37B | 369.30 | 1.62% |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.15 | £3.34B | 1,514.00 | 0.46% |
| HCM | Hutchmed China | AIM | £1.72B | 202.00 | 4.80% | |
| GNS | Genus | FTSE 250 | 1.26 | £1.69B | 2,545.00 | 0.39% |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £725.64M | 587.00 | -2.49% | |
| AGY | Allergy Therapeutics | AIM | £693.98M | 10.75 | -2.50% | |
| AVCT | Avacta Group | AIM | £342.41M | 71.00 | -7.00% | |
| PRTC | Puretech Health | FTSE Small Cap | £292.44M | 120.60 | -0.33% | |
| FARN | Faron Pharmaceuticals OY | AIM | £182.24M | 163.85 | 1.10% | |
| ANCR | Animalcare Group | AIM | 2.18 | £164.33M | 238.00 | -2.60% |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| STX | Shield Therapeutics | AIM | £118.92M | 11.50 | -7.90% | |
| DXRX | Diaceutics | AIM | £117.17M | 132.00 | -0.50% | |
| SCLP | Scancell Holdings | AIM | £105.85M | 10.20 | -1.10% | |
| ANP | Anpario | Main Market | 2.34 | £101.95M | 493.70 | -0.90% |
| 4BB | 4basebio | AIM | £100.6M | 632.66 | -0.40% | |
| BVXP | Bioventix | AIM | 8.57 | £91.44M | 1,693.60 | -2.20% |
| EAH | Eco Animal Health Group | AIM | £72.16M | 107.00 | -4.30% | |
| ANIC | Agronomics | AIM | £69.15M | 7.13 | -0.60% | |
| HVO | Hvivo | AIM | 3.08 | £44.22M | 6.63 | -5.10% |
| OBI | Ondine Biomedical Inc | AIM | £43.31M | 10.00 | 2.60% | |
| SBTX | SkinBioTherapeutics | AIM | £35.26M | 13.51 | -14.90% | |
| IMM | ImmuPharma | AIM | £31.07M | 6.30 | -3.00% | |
| AREC | Arecor Therapeutics | AIM | £30.21M | 80.50 | -1.30% | |
| ABDX | Abingdon Health | AIM | £29.25M | 6.55 | 2.60% | |
| POLB | Poolbeg Pharma | AIM | £26.84M | 4.08 | -2.10% | |
| SAR | Sareum Holdings | AIM | £18.64M | 17.80 | -5.60% | |
| EDEN | Eden Research | AIM | £12.8M | 2.40 | -2.40% | |
| VRCI | Verici Dx | AIM | £11.73M | 0.76 | -4.80% | |
| IXI | Ixico | AIM | £10.89M | 11.75 | -1.50% | |
| OBD | Oxford BioDynamics | AIM | £10.3M | 0.24 | -4.00% | |
| GDR | Genedrive | AIM | £9.27M | 0.88 | -1.60% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| PRM | Proteome Sciences | AIM | £7.41M | 2.10 | 8.00% | |
| OPTI | OptiBiotix Health | AIM | £6.97M | 6.66 | -3.30% | |
| FUM | Futura Medical | AIM | £6.67M | 1.22 | 14.60% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| VAL | ValiRx | AIM | £2.41M | 0.43 | -2.20% | |
| GUN | Gunsynd | AIM | £2.19M | 0.14 | 9.50% |